Shiriki Kumanyika, Ph.D., M.P.H., and William H. Dietz, M.D., Ph.D.
doi : 10.1056/NEJMp2029646
N Engl J Med 2020; 383:2197-2200
Tim Lahey, M.D., M.M.Sc.
doi : 10.1056/NEJMp2021953
N Engl J Med 2020; 383:2200-2201
Barry R. Bloom, Ph.D., Glen J. Nowak, Ph.D., and Walter Orenstein, M.D.
doi : 10.1056/NEJMp2025331
N Engl J Med 2020; 383:2202-2204
Adetomiwa V. Owoseni, B.S.
doi : 10.1056/NEJMp2027850
N Engl J Med 2020; 383:2204-2205
The Health Opportunity and Equity (HOPE) Initiative
doi : 10.1056/NEJMp2029139
N Engl J Med 2020; 383:e124
Sam Halabi, J.D., Andrew Heinrich, J.D., and Saad B. Omer, M.B., B.S., Ph.D., M.P.H.
doi : 10.1056/NEJMp2030600
N Engl J Med 2020; 383:e125
Yasmin Rafiei, B.Sc., and Michelle M. Mello, J.D., Ph.D.
doi : 10.1056/NEJMp2028209
N Engl J Med 2020; 383:e126
Thierry André, M.D., Kai-Keen Shiu, F.R.C.P., Ph.D., Tae Won Kim, M.D., Ph.D., Benny Vittrup Jensen, M.D., Lars Henrik Jensen, M.D., Ph.D., Cornelis Punt, M.D., Ph.D., Denis Smith, M.D., Rocio Garcia-Carbonero, M.D., Ph.D., Manuel Benavides, M.D., Ph.D., Peter Gibbs, M.D., Christelle de la Fouchardiere, M.D., Fernando Rivera, M.D., Ph.D.,
doi : 10.1056/NEJMoa2017699
N Engl J Med 2020; 383:2207-2218
Programmed death 1 (PD-1) blockade has clinical benefit in microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) tumors after previous therapy. The efficacy of PD-1 blockade as compared with chemotherapy as first-line therapy for MSI-H–dMMR advanced or metastatic colorectal cancer is unknown.
George L. Bakris, M.D., Rajiv Agarwal, M.D., Stefan D. Anker, M.D., Ph.D., Bertram Pitt, M.D., Luis M. Ruilope, M.D., Peter Rossing, M.D., Peter Kolkhof, Ph.D., Christina Nowack, M.D., Patrick Schloemer, Ph.D., Amer Joseph, M.B., B.S., and Gerasimos Filippatos, M.D. for the FIDELIO-DKD Investigators*
doi : 10.1056/NEJMoa2025845
N Engl J Med 2020; 383:2219-2229
Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and type 2 diabetes. However, its long-term effects on kidney and cardiovascular outcomes are unknown.
Valeria P. Mart?nez, Ph.D., Nicholas Di Paola, Sc.D., Daniel O. Alonso, B.Sc., Unai Pérez-Sautu, Ph.D., Carla M. Bellomo, Ph.D., Ayelén A. Iglesias, B.Sc., Rocio M. Coelho, B.Sc., Beatriz L?pez, B.Sc., Natalia Periolo, Ph.D., Peter A. Larson, Ph.D., Elyse R. Nagle, M.Sc., Joseph A. Chitty, B.Sc.,
doi : 10.1056/NEJMoa2009040
N Engl J Med 2020; 383:2230-2241
From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths. Understanding the genomic, epidemiologic, and clinical characteristics of person-to-person transmission of ANDV is crucial to designing effective interventions.
Titus K. Kwambai, M.D., Ph.D., Aggrey Dhabangi, M.D., Ph.D., Richard Idro, M.D., Ph.D., Robert Opoka, M.D., Victoria Watson, B.Sc., Simon Kariuki, Ph.D., Nickline A. Kuya, Dip.Clin.Med., Eric D. Onyango, B.Sc., Kephas Otieno, M.P.H., Aaron M. Samuels, M.D., M.H.S., Meghna R. Desai, Ph.D., Michael Boele van Hensbroek, M.D., Ph.D.,
doi : 10.1056/NEJMoa2002820
N Engl J Med 2020; 383:2242-2254
Children who have been hospitalized with severe anemia in areas of Africa in which malaria is endemic have a high risk of readmission and death within 6 months after discharge. No prevention strategy specifically addresses this period.
David C. Fajgenbaum, M.D., and Carl H. June, M.D.
doi : 10.1056/NEJMra2026131
N Engl J Med 2020; 383:2255-2273
Teena M. Mendonca, M.S., and Gladys R. Rodrigues, M.B., B.S., D.N.B.
doi : 10.1056/NEJMicm2024132
N Engl J Med 2020; 383:2274
Maja Boshkovska Spaseski, M.D., and Dejan Spaseski, M.D.
doi : 10.1056/NEJMicm2017137
N Engl J Med 2020; 383:e128
Danica M. Vodopivec, M.D., Dylan D. Thomas, M.D., Nadine E. Palermo, D.O., Devin W. Steenkamp, M.B., Ch.B., and Stephanie L. Lee, M.D., Ph.D.
doi : 10.1056/NEJMcps2004935
N Engl J Med 2020; 383:2275-2281
Axel Grothey, M.D.
doi : 10.1056/NEJMe2031294
N Engl J Med 2020; 383:2283-2285
Julie R. Ingelfinger, M.D., and Clifford J. Rosen, M.D.
doi : 10.1056/NEJMe2031382
N Engl J Med 2020; 383:2285-2286
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2034472
N Engl J Med 2020; 383:e140
Wadih Arap, M.D., Ph.D., Renata Pasqualini, Ph.D., and Joseph F. Costello, Ph.D.
doi : 10.1056/NEJMcibr2030475
N Engl J Med 2020; 383:2287-2290
doi : 10.1056/NEJMc2031364
N Engl J Med 2020; 383:2291-2293
doi : 10.1056/NEJMc2030710
N Engl J Med 2020; 383:2293-2294
doi : 10.1056/NEJMc2032361
N Engl J Med 2020; 383:e129
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟